Arthi Sridhar

Assistant Professor

University of Texas Southwestern Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Arthi Sridhar is an Assistant Professor at The University of Texas Southwestern Medical Center in the United States. Her research focuses on oncology, particularly in the areas of lung cancer treatment and the challenges faced by medical graduates in oncology fields. Recent publications include studies on chemotherapy protocols for NSCLC, global clinician practices in cancer management, and disparities in access to cancer care.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (1)

Amin Nassar

Yale University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Arthi Sridhar

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Consolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLC

Brief Report: Safety and Efficacy of Sequential Chemoimmunotherapy Followed by Concurrent Chemoradiation in Unresectable Stage III NSCLC

Going Back Home: Understanding the Challenges and Discrimination of Early and Mid-Career International and Puerto Rican Medical Graduates in Oncology Fields in the United States.

Combination of Lurbinectedin and Osimertinib for Treatment of <i>EGFR</i>-Mutated Transformed SCLC: A Brief Report.

Brief Report on Global Clinician Practices in the First-Line Management of Metastatic Non-Small Cell Lung Cancer

A Review of the Current Approach and Treatment Landscape for Stage III Non-Small Cell Lung Cancer

Precision Immuno-Oncology in NSCLC through Gender Equity Lenses

Major Stressful Life Events and the Risk of Pancreatic, Head and Neck Cancers: A Case–Control Study

Access to Cancer Care in LMIC - Navigating Current Challenges

Screening for renal cell carcinoma in renal transplant recipients: a single-centre retrospective study

Collaborators (1)

Amin Nassar

Make your next move.

Arthi Sridhar

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Consolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLC

Brief Report: Safety and Efficacy of Sequential Chemoimmunotherapy Followed by Concurrent Chemoradiation in Unresectable Stage III NSCLC

Going Back Home: Understanding the Challenges and Discrimination of Early and Mid-Career International and Puerto Rican Medical Graduates in Oncology Fields in the United States.

Combination of Lurbinectedin and Osimertinib for Treatment of &lt;i&gt;EGFR&lt;/i&gt;-Mutated Transformed SCLC: A Brief Report.

Brief Report on Global Clinician Practices in the First-Line Management of Metastatic Non-Small Cell Lung Cancer

A Review of the Current Approach and Treatment Landscape for Stage III Non-Small Cell Lung Cancer

Precision Immuno-Oncology in NSCLC through Gender Equity Lenses

Major Stressful Life Events and the Risk of Pancreatic, Head and Neck Cancers: A Case–Control Study

Access to Cancer Care in LMIC - Navigating Current Challenges

Screening for renal cell carcinoma in renal transplant recipients: a single-centre retrospective study

Collaborators (1)

Amin Nassar

Make your next move.

Combination of Lurbinectedin and Osimertinib for Treatment of <i>EGFR</i>-Mutated Transformed SCLC: A Brief Report.